✨
Yapay Zeka Hızlı Bakış & Çıkarımlar
AI Insight⚡ TL;DR(1 Cümlede Hızlı Çıkarım)
After sepsis treatment with imipenem-cilastatin and aminoglycoside, remission of hemophagocytosis was achieved.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Secondary hemophagocytic syndrome may develop during certain severe infections commonly due to viral infections, but is rarely associated with bacterial infections, and its appearance in a premature newborn is uncommon.
📊
Temel Bulgular & Veri:We present a case of hemophagocytosis during Pseudomonas aeruginosa septicemia in a premature infant.
💡
Sonuç & Katkı:After sepsis treatment with imipenem-cilastatin and aminoglycoside, remission of hemophagocytosis was achieved.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Secondary hemophagocytic syndrome may develop during certain severe infections commonly due to viral infections, but is rarely associated with bacterial infections, and its appearance in a premature newborn is uncommon. We present a case of hemophagocytosis during Pseudomonas aeruginosa septicemia in a premature infant. After sepsis treatment with imipenem-cilastatin and aminoglycoside, remission of hemophagocytosis was achieved.
🔖
Bu Makaleye Atıf Yap
TEKİNALP, G., GÜRGEY, A., ASLAN, D., ALİEFENDİOĞLU, D. (2022). Pseudomonas sepsis with neutrophagocytosis in a premature newborn. Turkish Journal of Pediatrics, Cilt: 42 - Sayı: 4, 328–330. https://ajindex.com/articles/613561